血外体蛋白质学识别不同表达的蛋白质作为急性心肌梗塞的生物标志物
Jie Zhou1,2,3, Hai-Tao Hou1,2,3, Huan-Xin Chen1,2,3
1Department of Cardiac Surgery & The Institute of Cardiovascular Diseases, TEDA International Cardiovascular Hospital, Tianjin University, Tianjin 300457, China.
Biomolecules
|April 30, 2025
概括
研究人员在心肌梗塞 (MI) 患者中发现了新的外体蛋白质. 这些蛋白质,包括F13A1和TSPAN33,显示出作为MI的诊断生物标志物和治疗点的潜力.
科学领域:
- 心血管生物学 心血管生物学
- 蛋白质组学是指蛋白质组学.
- 异构体生物学 异构体生物学
背景情况:
- 心肌梗塞 (MI) 仍然是全球死亡和住院的主要原因.
- 外体体在细胞间通信中起着关键的作用,影响生理和病理过程.
- 了解外体组件可以了解疾病机制和潜在的治疗策略.
研究的目的:
- 鉴定和描述心肌梗塞 (MI) 患者的血外体内差异表达蛋白 (DEPs).
- 发现新的外体蛋白生物标志物,用于早期检测和诊断心脏病发作.
- 探索潜在的外体治疗点来治疗心脏病发作.
主要方法:
- 蛋白质组学分析用于识别来自ST升高MI (STEMI),非ST升高MI (NSTEMI),不稳定性心痛和健康对照患者的血中的外体DEP.
- 并行反应监测 (PRM) 用于在一个独立的患者队列中验证已识别的DEP的一个子集.
- 进行了生物信息学分析,以阐明与验证的外体DEP相关的分子机制.
主要成果:
- 与对照人群相比,蛋白质组分析在心脏病发作患者中发现了406种外体DEP.
- 七种外体DEP (STEMI中的F13A1,TSPAN33,YWHAZ;STEMI中的F13A1,TSPAN33,ITGA2B,GP9,GP5,PPIA) 已经成功验证.
- 与对照组相比,所有经过验证的DEP在心脏病发作患者中都显著下调,呈现出高灵敏度和特异性.
结论:
- 该研究确定了七种特定的外体蛋白质作为潜在的MI诊断生物标志物.
- 这些经过验证的外体DEP可能成为MI的新型治疗点.
- 这些发现提供了对MI病原体背后的分子机制的宝贵见解.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
71
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
71
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
38
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
38


